Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04900090Not ApplicableCompleted

Tahiti-families: Polynesian Families of Gout Patients

Role: collaborator

NCT04812886Not ApplicableCompleted

Epidemiology of Gout in French Polynesia

Role: collaborator

NCT07343336Recruiting

Landscape of Gout in French Polynesia.

Role: collaborator

NCT05607797Not ApplicableCompleted

Genetic of Chronic Kidney Disease and Gout in New Caledonia

Role: collaborator

All 4 trials loaded